Skip to main content
Log in

Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

A prospective study was performed to evaluate the efficacy of chlorambucil in inducing long-term remission in children with steroid-dependent or cyclophosphamide-resistant primary nephrotic syndrome (NS). The 15 steroid-dependent children had a relapse rate of 5.3/patient per year (range 4–8) and a mean age of 8.4 years (range 2–13). The chlorambucil dosage was 0.2 mg/kg per day for a total of 8 weeks. Nine patients (56%) remained in complete remission for an average of 39.2 months (range 16–70). The interval to the first relapse in the remaining 7 ranged from 4 to 41 months and the relapse rate decreased significantly to 0.6 relapses/patient per year (P<0.05). Five children had steroid- and cyclophosphamide-resistant NS, 4 with focal segmental glomerulosclerosis and 1 with mesangiol proliferative glomerulonephritis. Chlorambucil was given in a dose of 0.2 mg/kg per day for 8–16 weeks. Complete remission was obtained in 4 patients; 2 patients relapsed. No serious long-term complications were observed in our patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arbeitsgemeinschaft für paediatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306: 451–454

    Google Scholar 

  2. Elzouki AY, Jaiswal OP (1988) Long-term small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood effect on remission, statural growth, obesity and infection rate. Clin Pediatr 27: 387–392

    Google Scholar 

  3. Tejani A, Nicastri A, Adamson O, Phadke K, Trachtman H (1983) Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis. Nephron 35: 225

    PubMed  Google Scholar 

  4. Yoshikawa N, Ito H, Akamatsu R, Matsuyama S, Hasegowa O, Nakahora C, Matsuo T (1986) Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 109: 65–70

    PubMed  Google Scholar 

  5. Arbeitsgemeinschaft für paediatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of 8 weeks with 12 weeks course. Arch Dis Child 62: 1102–1106

    Google Scholar 

  6. Elzouki AY, Amin F, Jaiswal OP (1984) Primary nephrotic syndrome in Arab children. Arch Dis Child 59: 253–255

    PubMed  Google Scholar 

  7. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children, prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13: 15

    Google Scholar 

  8. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98: 561–564

    Google Scholar 

  9. Grupe WE, Makker SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295: 746

    PubMed  Google Scholar 

  10. Grupe WE (1973) Chlorambucil in steroid-dependent nephrotic syndrome. J Pediatr 82: 598–606

    PubMed  Google Scholar 

  11. William SA, Makker SP, Ingelfinger JR, Grupe WE (1980) Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of children. N Engl J Med 302: 929–933

    PubMed  Google Scholar 

  12. Guesry P, Lenoir G, Broyer M (1978) Gonadal effects of chlorambucil given to pre-pubertal and pubertal boys for nephrotic syndrome. J Pediatr 92: 299–303

    PubMed  Google Scholar 

  13. Baluarte HJ, Hiner L, Gruskin AB (1978) Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial. J Pediatr 92: 295–298

    PubMed  Google Scholar 

  14. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33: 729–734

    PubMed  Google Scholar 

  15. Maher ER, Sweng P, Chappel M, Varghese Z, Moorhead JF (1988) Cyclosporin in treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 3: 728–732

    PubMed  Google Scholar 

  16. Brodehl J, Hoyer PF (1985) Cyclosporin treatment of idiopathic nephrotic syndrome in children. In: Schindler R (ed) Cyclosporine in autoimmune disease. Springer New York Berlin Heidelberg, pp 329

    Google Scholar 

  17. Spitzer A, Gordillo PG, Houston IB, Travis LB (1974) Prospective controlled study of cyclophosphamide therapy in children with nephrotic syndrome. Report of international study of kidney disease in childhood. Lancet II: 423–427

    Google Scholar 

  18. Moncrieff MW, White RHR, Ogg CS, Cameron JS (1969) Cyclophosphamide therapy in nephrotic syndrome in childhood. Br Med J 1: 666

    PubMed  Google Scholar 

  19. Pascual JF, Molina M, Lopez J (1981) Long-term assessment of chlorambucil in children with nephrotic syndrome who fail to respond adequately to corticosteroid. Contrib Nephrol 27: 65–74

    PubMed  Google Scholar 

  20. Callis L, Nieto J, Vila A, Renade J (1980) Chlorambucil treatment in minimal lesion nephrotic syndrome — a reappraisal of its gonadal toxicity. J Pediatr 97: 653–656

    PubMed  Google Scholar 

  21. Palmar Rg, Denman AM (1984) Malignancies induced by chlorambucil. Cancer Treat Rev 11: 121–129

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elzouki, A.Y., Jaiswal, O.P. Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis. Pediatr Nephrol 4, 459–462 (1990). https://doi.org/10.1007/BF00869820

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00869820

Key words

Navigation